Correction to: Human umbilical cord-derived mesenchymal stem cells protect against experimental colitis via CD5+ B regulatory cells
The original article [1] contains a duplication error within Figure 3.
Main Authors: | Kang Chao, Shenghong Zhang, Yun Qiu, Xiaoyong Chen, Xiaoran Zhang, Chuang Cai, Yanwen Peng, Ren Mao, Meirav Pevsner-Fischer, Shomron Ben-horin, Eran Elinav, Zhirong Zeng, Baili Chen, Yao He, Andy Peng Xiang, Minhu Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-01-01
|
Series: | Stem Cell Research & Therapy |
Online Access: | http://link.springer.com/article/10.1186/s13287-019-1132-1 |
Similar Items
-
Human umbilical cord-derived mesenchymal stem cells protect against experimental colitis via CD5+ B regulatory cells
by: Kang Chao, et al.
Published: (2016-08-01) -
Surgical management of inflammatory bowel disease in China: a systematic review of two decades
by: Qiao Yu, et al.
Published: (2016-10-01) -
A Novel Model Based on Serum Biomarkers to Predict Primary Non-Response to Infliximab in Crohn’s Disease
by: Li Li, et al.
Published: (2021-07-01) -
Curcumin-QingDai Combination as Treatment for Moderate-Severe Ulcerative Colitis
by: Shomron Ben-Horin, et al.
Published: (2022-09-01) -
Hypermethylation of miR-145 promoter-mediated SOX9-CLDN8 pathway regulates intestinal mucosal barrier in Crohn's disease
by: Xiaojun Zhuang, et al.
Published: (2022-02-01)